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ABSTRACT
Riboswitches are RNA-based regulatory devices that
mediate ligand-dependent control of gene expres-
sion. However, there has been limited success in
rationally designing riboswitches. Moreover, most
previous riboswitches are confined to a particular
gene and only perform one-way regulation. Here,
we used a library screening strategy for efficient cre-
ation of ON and OFF riboswitches of lacI on the
chromosome of Escherichia coli. We then engin-
eered a riboswitch-LacP hybrid device to achieve
portable gene control in response to theophylline
and IPTG. Moreover, this device regulated target ex-
pression in a ‘two-way’ manner: the default state of
target expression was ON; the expression was swit-
ched off by adding theophylline and restored to the
ON state by adding IPTG without changing growth
medium. We showcased the portability and two-way
regulation of this device by applying it to the small
RNA CsrB and the RpoS protein. Finally, the use of
the hybrid device uncovered an inhibitory role of
RpoS in acetate assimilation, a function which is
otherwise neglected using conventional genetic ap-
proaches. Overall, this work establishes a portable
riboswitch-LacP device that achieves sequential
OFF-and-ON gene regulation. The two-way control
of gene expression has various potential scientific
and biotechnological applications and helps reveal
novel gene functions.
INTRODUCTION
Inducible gene regulation is required for diverse applica-
tions such as gene function investigations, gene therapies
and industrial uses. So far, inducible promoters are the
major tools for specifically controlling target gene expres-
sion. However, there are only limited numbers of inducible
promoters which, on some occasions, are insufficient for
independent control of multiple genes by the addition of
distinct inducers. It is, therefore, highly desirable to de-
velop alternative approaches to enrich the repertoire of in-
ducible systems. A promising candidate is riboswitch that
is a RNA-based, ligand-dependent genetic control element
located in non-coding regions of messenger RNAs.
Riboswitches control biological processes at various regu-
latory levels. Lysine riboswitches prematurely halt RNA
transcription by modulating the formation of a Rho-
independent terminator (1–3). Translationally controll-
ing riboswitches in the 50-untranslated region modulate the
ribosome access to the ribosome-binding site (RBS) (4–6).
In addition, some riboswitches undergo self-cleavage upon
ligand binding, resulting in rapid RNA degradation (7,8).
Unlike inducible promoters, these RNA-based control elem-
ents are potentially numerous as a result of high-throughput
screen for ligand-specific aptamers (the sensor domain of a
riboswitch) (9–13).
In recent years, advancements have been made in the
ability to convert ligand-specific aptamers to functionally
active riboswitches by various random screening approaches
(14–16) or rational design (4,5,8). However, library
screening is labor intensive and time consuming, and suc-
cessful rational design is not guaranteed even though a
long list of design principles are followed, due to incom-
plete understanding of RNA-based gene regulation mech-
anisms. In addition, a common disadvantage of
riboswitches as well as inducible promoters is that they
only allow for one-way gene regulation. Once activated,
a target gene cannot be turned off unless promoter in-
ducers or riboswitch ligands are removed. The one-way
regulation mode makes the existing regulation systems un-
suitable for quick gene control in live animals or in vitro
studies where intact cell cultures are required. Thus, there
is a great need for a two-way regulation system, in which
target gene can be switched off and on in response to
distinct effector molecules.
Here, we set out to develop a portable and two-way
regulatory device by integrating an ON theophylline-
responsive riboswitch with the lac-inducible promoter sys-
tem (abbreviated as LacP), in which the LacI repressor
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binds as a homotetramer to two LacI-binding sites pos-
itioned immediately downstream of the lac promoter.
First, we used a library screening strategy to create ON
and OFF theophylline-responsive riboswitches of the lacI
gene that encodes the LacI transcriptional regulator.
Then, combining an ON-riboswitch of LacI synthesized
in the first part of this study with two LacI-binding sites
(LacIbs), we established a portable hybrid device that
acted as a versatile key for controlling gene expression
without the need for further rational design or library
screening. We demonstrated the portability of this device
by applying it to rpoS (encoding RpoS, a master regulator
of acid resistance) and csrB (encoding a small non-coding
RNA CsrB). We showed that this portable device regu-
lates target genes in a two-way manner, switching off the
targets in response to theophylline and restoring the target
expression in response to isopropyl b-D-1-thiogalacto-
pyranoside (IPTG). The sequential two-way control of
RpoS and CsrB by the riboswitch-LacP hybrid device re-
versibly fine-tuned virulence-associated cellular behaviors
including acid resistance, intercellular autoaggregation
and biofilm formation. Finally, we used this device to
explore unidentified functions of RpoS and revealed for
the first time that removing RpoS promotes acetate as-
similation after the acetate switch is flipped. This finding
is opposite to the previous ones made by using conven-
tional rpoS mutants, which might have accumulated sec-
ondary mutations. Since the portable two-way device does
not silence target genes until theophylline is added, its host
cells are less likely to generate secondary mutations and
therefore able to provide more reliable information.
MATERIALS AND METHODS
Bacterial strains, plasmids and growth conditions
Escherichia coli strain MG1655 was used in this study. All
bacterial mutants were grown at 37C, with shaking at
220 rpm, in Luria–Bertani (LB) medium supplemented
with 2mM magnesium sulfate. The antibiotics ampicillin
(50mg/ml), kanamycin (50 mg/ml) and chloramphenicol
(12.5 mg/ml) were used for selection when appropriate.
Mutagenesis
Gene deletion was performed using the recombineering
system (17). Escherichia coli-K12 MG1655 was trans-
formed with plasmid pSim6 (a gift from Dr Donald
Court) from which the expression of the  recombination
proteins is induced at 42C. PCR fragments encompassing
a loxP-cat-loxP with homology (45 nt) to the regions im-
mediately flanking each deletion locus were transformed
via electroporation into MG1655 cells harboring pSim6.
After induction of red functions, recombinants were
selected for chloramphenicol resistance (encoded by the
cat gene) and were further verified by colony PCR.
Construction of randomized riboswitch libraries
For construction of theophylline-responsive riboswitch
libraries on the chromosome, the loxP-cat-loxP fragment
was linked to a theophylline-responsive aptamer followed
by a 5-nt-random sequence by ligation PCR. The resulting
PCR products with homology (45 nt) to the regions sur-
rounding the ribosome-binding site of each target gene
were then integrated into the chromosome using the
above-described recombineering technique. In theory,
each thus established library contains 45 riboswitch
candidates.
Construction of chromosomal lacZ translational fusions
and b-galactosidase assays
The loxP-cm-loxP selectable cassette was inserted imme-
diately after the stop codon of the lacZ gene on the
MG1655 chromosome using recombineering (as described
above). Next, the lacZ-loxP-cm-loxP cassette was PCR
amplified and inserted (in frame) immediately prior to
the stop codon of the target gene on the chromosome.
The inserted lacZ fragment started from the eighth
codon of lacZ gene and was co-transcribed and translated
with the fused genes. The expression of gene-lacZ fusions
was quantified using a b-galactosidase assay as described
previously (4,18). Levels of b-galactosidase were
calculated using the following formula:
Units ðUÞ ¼ OD420  1000=ðOD600
 hydrolysis time volume of lysateÞ:
Acid resistance assay
Overnight cultures were treated with acid (pH 2) for 2 h
and then serially diluted in neutral medium. After over-
night culture, colony forming units (CFU) of acid-treated
and untreated cells were determined. Acid survival (%)
was calculated with the following formula:
Acid survival ð%Þ ¼ 100 ðCFU of treated=
CFU of untreatedÞ
Autoaggregation
Overnight cultures were diluted 1:500 and incubated at
37C, with shaking at 220 rpm, in liquid LB medium.
When cells aggregated (visualized macroscopically by the
clumping or ‘fluffing’ of cells in liquid cultures), 100 ml of
each cell suspension was transferred to flat-bottom 96-well
plates (Iwaki, Tokyo, Japan) and the images of the cell
aggregates were captured by scanning. To better visualize
the cell aggregates, 1 ml of crystal violet (0.1%) was added
to each cell suspension immediately prior to image capture.
Cellular autoaggregation was also examined microscop-
ically. Cell suspensions were spread on a microscope slide,
heat-fixed, stained with DAPI (406-diamidino-
2-phenylindol) and imaged using a fluorescence stereo-
microscope SZX12 (Olympus, Tokyo, Japan) with DAPI
filter sets.
Biofilm formation
Biofilms were formed on polystyrene, flat-bottom 96-well
microtiter plates (Iwaki, Tokyo, Japan). Two hundred
microliters of each cell suspension (105 cells/ml) was trans-
ferred into each well of a microtiter plate and incubated
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for 24 h at 37C in a shaker at 75 rpm. Resulting biofilms
were washed thrice with PBS and air dried. Then, biofilms
were stained with 100ml of 0.4% aqueous crystal violet
solution for 15min. Afterward, biofilms were washed
thrice with sterile distilled water and immediately de-
stained with 200 ml of 95% ethanol. After 30min of de-
staining, 100 ml of destaining solution was transferred to a
new well and measured with a microtiter plate reader
(SpectraMAX 340 Tunable Microplate Reader;
Molecular Devices Ltd) at 595 nm.
Semi-quantitative RT–PCR
Total RNA was isolated from overnight cultures in LB
medium. Subsequently, 2 mg of RNA was reverse trans-
cribed in a total reaction volume of 20ml using the
ThermoScript RT-PCR system (Invitrogen). Each reaction
was incubated at 55C for 50min followed by 15min at
70C. Two microliters of the resulting reverse transcript
products (cDNA) were then used for 18, 20, 22 and 24
rounds of PCR (30 s each at 94C, 55C, and 72C) with
Ex Taq DNA polymerase (Takara Bio, Inc.) and primers
complementary to csrB (RT-CsrB-F: 50-GTCAGACAAC
GAAGTGAACATCAGG-30 and RT-CsrB-R: 50-GGAG
CACTGTATTCACAGCGCT-30) and the 16S rRNA
gene (RT-16S-F: 50- CTCCTACGGGAGGCAGCAG-30
and RT-16S-R: 50-CTCCGTATTACCGCGGCTG-30) to
co-amplify the gene of interest and the internal control.
PCR products were separated in 1.5% agarose gel.
Acetate determination
To quantify extracellular acetate, cell suspensions were
centrifuged at 10 000 rpm for 5min at 4C. The resulting
supernatants were then subjected to acetate determination
using an acetate detection kit (Megazme, Bray, Ireland)
according to the manufacturer’s instructions.
Statistical analysis
Paired t-tests were used to compare the two means ob-
tained from b-galactosidase assays; one-way ANOVA
was used for the comparison of multiple means from the
biofilm formation assay. P< 0.05 was considered statistic-
ally significant.
RESULTS
Establishment of a random library for engineering
functionally active riboswitches on the chromosome
To construct a riboswitch-LacP hybrid device, our first
task was engineering ligand-responsive riboswitches for
the lacI gene, which encodes the LacI transcriptional regu-
lator in the Lac system. Previously, we have successfully
engineered a theophylline-responsive ON riboswitch resid-
ing upstream of the csrA gene in E. coli and managed to
modulate the accessibility to ribosome binding and to
flexibly control the csrA expression (4). However, the ribo-
switch did not work when grafted to lacI (data not
shown), indicating that riboswitches besides the RBS are
sensitive to changes in flanking regions and have to be spe-
cifically designed and constructed for each target gene.
However, rational design is laborious and does not guar-
antee successful engineering of functionally active ribo-
switches. We, therefore, sought out to explore the
possibility of establishing a chromosomal riboswitch
library, with the aid of the recombineering technique, to
screen for active riboswitches.
We used the theophylline-responsive aptamer as the sen-
sor domain of our riboswitches. The riboswitches were
proposed to adopt multiple conformations at equilibrium,
some of which permitted downstream target expression
whereas some of which did not. If theophylline binding
to the aptamer favored the formation of conformations
that permitted target expression, then the riboswitch was
an ON switch. Conversely, if theophylline binding shifted
the equilibrium distribution to conformations that re-
pressed the target expression, the riboswitch was an
OFF switch.
To engineer a theophylline-responsive riboswitch for
lacI, we first constructed a riboswitch library and then
screened for clones that could effectively control the target
expression in response to theophylline (Figure 1A and B).
We used the genomic DNA isolated from the previously
reported switch-csrA strain (4) to PCR amplify the
theophylline-specific aptamer fragment. Then, the aptamer
was linked to a chloromphenical resistance gene (cat) by
ligation PCR, generating a riboswitch cassette library con-
taining a cat-aptamer-linker-random fragment on the
chromosome. The cat gene facilitates recombineering of
the cassette into the genome, and the 5-nt-random se-
quence allows construction of a riboswitch library. The
cassette was integrated, using the recombineering tech-
nique, into the genome of the E. coli MG1655 strain
right upstream of the RBS of target genes, resulting in
numerous mutant strains each of which carried a ribo-
switch candidate (functional or nonfunctional) on the
chromosome. In theory, the mutant library contained 45
riboswitch candidates.
Effective ON and OFF riboswitches of the lacI gene are
constructed using the efficient library screening approach
LacI is a well-known repressor of lacZ and therefore the
expression of lacI can be detected on X-gal plates.
However, we did not use this strategy but instead con-
structed a lacI–lacZ translational fusion on the chromo-
some of a MG1655 lacZ null mutant, to illustrate that the
library screening on X-gal plates allows for construction
of riboswitches for any target genes fused with lacZ. To
engineer an ON riboswitch of lacI, the riboswitch cassette
cat-aptamer-linker-random sequence was integrated up-
stream of the RBS of the lacI–lacZ fusion on the chromo-
some by recombineering (Figure 1A). Then, the resulting
mutant collection was placed on agar with 0.06mg/ml
X-gal and 2mM caffeine (used as a negative control whose
chemical structure differs from theophylline only by the
additional presence of one methyl group) but without
theophylline. Approximately 2000 colonies were checked
for color, and two clones were whiter than others. Both
clones turned into blue when re-streak on X-gal plates plus
2mM theophylline. The riboswitches in the two clones
were sequenced and the random sequence was TGTAT
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and CGTAT, respectively. The riboswitch carrying TGTAT
was named ON1-lacI, and the one with CGTAT was
named ON2-lacI. The effectiveness of the two ON
riboswitches of lacI was confirmed by b-galactosidase as-
say comparing lacI–lacZ fusion levels in the presence of
either caffeine or theophylline (Figure 1C).
To screen for effective OFF riboswitches of lacI, ap-
proximately 3000 blue colonies on the caffeine-
supplemented X-gal plates were re-streak on plates plus
2mM theophylline (Figure 1B). After 6 h culture, one
clone gave whiter color relative to others. Its responsive-
ness to theophylline was verified by b-galactosidase assay
(Figure 1C), indicating that the clone carries an OFF
riboswitch of lacI. We named it OFF-lacI. Sequencing
analysis revealed that the 5-nt random sequence in OFF-
lacI is CTGGT.
The artificial riboswitches control the lacI expression via a
long stem structure adjacent to the ribosome-binding site
Secondary structures of the ON and OFF riboswitches of
lacI were then predicted using RNAstructure 5.1 (19,20).
The secondary structure prediction of all the riboswitches
was performed for a 237-nt long fragment starting with a
33-nt stem–loop structure (136 nt relative to the transla-
tional start site) and ending at the 100th nucleotide of lacI.
For each riboswitch, the optimal structure with the
minimum free energy was chosen for the structure analysis.
To predict riboswitch structures in the ligand-bound form,
we utilized the ‘force pair’ function of RNAstructure 5.1
to force the theophylline binding pocket to form.
The structure analysis revealed that ON1-lacI in the
non-ligand-bound state forms a 9-bp stem immediately
adjacent to the RBS (Figure 2A). This long stem exists
in not only the optimal structure but also alternative struc-
tures with higher free energy (data not shown). Except for
the first nucleotide, the random sequence contributes to
the formation of the stem. When theophylline binds to the
riboswitch, the conformation changes and the long stem
adjacent to the RBS does not form (Figure 2A). In ON2-
lacI, the same was found (Figure 2B). Interestingly, the
5-nt random sequences of the two ON riboswitches share
the latter 4 nt, which is unlikely to be coincident. We
proposed that the latter four nucleotides GUAU is critical
for the action of ON1-lacI and ON2-lacI by being part of
the long stem immediately upstream of the RBS. If this is
true, then the riboswitch OFF-lacI in the absence of theo-
phylline would not contain a long stem next to the RBS,
allowing for the gene translation; but would form the stem
structure when bound by the ligand, repressing the expres-
sion. As shown in Figure 3A, the predicted structures of
OFF-lacI in the presence and in the absence of theophyl-
line are totally in agreement with this hypothesis.
Figure 1. Creation of ON and OFF riboswitches for the lacI gene using a library screening-based method. (A) A random cassette mixture containing
a theophylline-responsive aptamer and five random bases was ‘recombineered’ into the chromosome of a MG1655 mutant that was defective in
native lacZ but carried the lacI–lacZ translational fusion, generating a riboswitch library for lacI. Cells were placed on X-gal plates without
theophylline but with 2mM caffeine. Relatively whiter colonies were searched for and transferred to X-gal plates with 2mM theophylline. Those
that turned into blue were considered to carry ON riboswitches of lacI. (B) Cells were placed on X-gal plates without theophylline but with 2mM
caffeine. Blue colonies were searched for and transferred to X-gal plates with 2mM theophylline. Those that turned into relatively white were
considered to carry OFF riboswitches of lacI. (C) Evaluation of the ON and OFF riboswitches of lacI using b-galactosidase assay. The mutant strain
(named lacI–lacZ) that carries the lacI–lacZ translational fusion without the ON riboswitch was used as a control.
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According to the prediction of free energy using RNA
structure 5.1, all the structures in the non-bound state
have lower free energy than the structures in the ligand-
bound state (Figures 2 and 3), and therefore are proposed
to predominate in the absence of theophylline. Only when
theophylline binds to the riboswitches would the equilib-
rium distribution be shifted to the formation of structures
with a theophylline-binding pocket, switching ON or OFF
the target. To confirm the role of a long stem adjacent to
RBS in the riboswitch-mediated gene control, we integ-
rated a long stem (10 nt)–loop structure immediately up-
stream of the RBS of lacI fused with lacZ (Figure 3B). In
the resulting mutant named Stem–lacI–lacZ, the expres-
sion levels of the lacI–lacZ fusion were reduced by 74% as
a result of the insertion of the long stem (Figure 3B).
Taken together, the synthetic riboswitches regulate lacI ex-
pression by forming or disrupting a long stem (9–10nt) im-
mediately upstream of the RBS in response to theophylline.
ON-lacI–LacIbs acts as a magnified, tunable and
two-way riboswitch device
Although the above-described riboswitches managed to
fine-tune their target genes in response to theophylline
and modulate corresponding biological processes, they had
following limitations. First, they did not restore wild-type
levels in the ON state (i.e. low ligand-saturating target
levels) and failed to completely shut off the target genes
in the OFF-state (i.e. high target leakage) (Figure 1C).
Second, these riboswitches performed either ON or OFF
function and thus were ‘one-way’ switches. It would be
desirable to develop a ‘two-way’ device that not only swi-
tches off but also switches on gene expression without
changing growth medium. Here, we utilized a ligand-
responsive riboswitch in combination with the LacI
protein and LacIbs to solve these problems. Given that
the two ON ribowitches are equally effective in controlling
lacI and both have a wider dynamic range than OFF-lacI
(Figure 1C), we chose ON1-lacI for the construction of the
riboswitch-LacP hybrid device.
LacI is a transcriptional repressor and inhibits lacZ
transcription by binding to two LacIbs upstream of
lacZ. Although the cells carrying ON1-lacI displayed high
basal levels of LacI in the ligand-free form and had only
1-fold increase in LacI levels in the ligand-bound form
(Figure 1C), the narrow dynamic range of the ON1-lacI
riboswitch would be magnified when the LacI repressor in
Figure 2. Predicted structures of the riboswitches ON1-lacI (A) and ON2-lacI (B). In the non-ligand-bound state, there is a 9-bp stem structure
immediately upstream of the ribosome binding site and is likely to block the gene translation. In the theophylline-bound state, the long stem does not form
and consequently permits the gene translation. The random sequence is shown in red; the ribosome binding site in blue; and the start codon in green.
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turns controlled its downstream target. To test this possi-
bility, we integrated the ON riboswitch upstream of the
intact lacI gene (not fused with lacZ). The LacI protein
represses expression of lacZ so that the ON riboswitch
indirectly switches off lacZ in response to theophylline.
In support of the above magnification hypothesis, ON1-
lacI when equipped with two LacIbs (upstream of lacZ)
displayed little leaky repression on lacZ in the presence of
caffeine but in the absence of theophylline, and almost
completely switched off lacZ when theophylline was
added to the cells (Figure 4A). Thus, LacI as an intermedi-
ary modulator can greatly increase the dynamic range and
improve the performance of the ON riboswitch. ON1-lacI
equipped with LacI and two LacIbs was hereinafter
referred to as ON-lacI–LacIbs.
Using LacI in the riboswitch device also makes possible
sequential two-way gene regulation as the LacI protein
can be inactivated by isopropyl b-D-1-thiogalactopyrano-
side (IPTG). Thus, adding theophylline should switch
on lacI and repress target genes of LacI, whereas adding
IPTG should inactivate LacI and derepress the targets.
The sequential control was verified by determining
b-galactosidase levels of the cells carrying the ON1-lacI
switch and intact lacZ. Theophylline and IPTG regulated
lacZ in opposite directions in a concentration-dependent
manner (Figure 4B). The effective concentration range
of theophylline was 100–1600 mM. Theophylline concen-
trations <100 mM gave little regulation and those higher
than this range failed to cause additional repression. When
IPTG was added to the medium containing 1600mM
theophylline, lacZ was derepressed. The effective range of
IPTG was 0.16–40 mM. In addition, we performed time-
course experiments to further characterize the response
of ON-lacI–LacIbs to theophylline and IPTG. All the
data were normalized to those of the same strain grown
in LB plus 1600mM caffeine. As shown in Figure 4C,
the hybrid device switched off 66% of the LacZ
activity within 30min after the addition of 1600 mM theo-
phylline. Maximum silencing (98% of the LacZ activity
was switched off) was observed at 120min. Forty micro-
meter IPTG was then added to the culture and switched
on the lacZ expression rapidly. Within 90min after
the IPTG addition, 85% of the LacZ activity was
restored.
Application of ON-lacI–LacIbs to portable, tunable
and two-way regulation of sigmaS (RpoS) subunit
of RNA polymerase
Inducible gene control built on binding of LacI to LacIbs
has been widely used for various non-lacZ genes in pro-
karyotic and eukaryotic cells (21–25), showing that the
inducibility of the LacI-responsive promoters are less likely
to be affected by downstream targets than that of ribo-
switches. Thus, the ON-lacI–LacIbs hybrid device should
be capable of regulating any target gene when integrated
Figure 3. Predicted structures of the riboswitch OFF-lacI and the long stem besides the ribosome binding site in the mutant Stem–lacI. (A) In OFF-
lacI, a 9-bp stem structure forms immediately upstream of the ribosome binding site in the absence of theophylline but does not exist in the presence
of the ligand. The random sequence is shown in red; the ribosome binding site in blue; and the start codon in green. (B) In Stem–lacI, there is a
10-bp stem structure located immediately upstream of the ribosome binding site. LacZ activity of the strain Stem–lacI–lacZ was determined using the
b-galactosidase assay. The ribosome binding site is shown in blue, and the start codon in green.
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upstream of the RBS. We next showcased the portability
of this device by applying it to the rpoS gene.
RpoS is an alternative sigma factor of RNA polymer-
ase, governing expression of over 200 genes (26,27) and
playing a critical role in survival of a diverse number of
stresses such as acid shock (28,29), osmotic stress (30),
heat shock (31), oxidative damage (29,32) and starvation
(29,33). RpoS negatively regulates Salmonella virulence
(29) and has, therefore, been mutated to engineer live
attenuated vaccine strains (34,35). Given the significance
of RpoS as a global response regulator and its potential
medical use, it is desired that the rpoS gene could be
placed under the control of the ON-lacI–LacIbs hybrid
device for tunable and two-way expression control. To
do this, we PCR amplified the ON-lacI–LacIbs cassette
(2500 bp) from the genome of the strain carrying the ON
riboswitch of lacI. The cassette is composed of the cat
gene, the ON-lacI riboswitch, the lacI gene and the lacI–
lacZ intergenic region containing the lac promoter (LacP)
with two LacIbs. The cat gene facilitates integration of
this cassette immediately upstream of any target gene via
recombineering. Next, we simply integrated the riboswitch
cassette upstream of the RBS of the rpoS gene, without
adjusting the sequence of the device. Then, the native
lacI gene was deleted from this strain, generating a new
strain named ON-lacI–rpoS (Figure 5A). This strain
was used to test if rpoS could be controlled by the
theophylline-responsive and LacI-repressible regulation
cassette. Since rpoS is required for acid resistance, we
assayed survival of the strain under acidic conditions. We
observed that the rpoS expression was on in the presence of
caffeine and the absence of theophylline as revealed by
normal survival percentage compared to the wild-type
strain after 2-h acid treatment (pH 2) (Figure 5B). This
was because the switch turned off lacI and therefore rpoS
was in the ON state. When theophylline was added, the
cells became sensitive to acid (Figure 5B), indicating that
the addition of theophylline turned on the expression of
lacI and the latter repressed the expression of rpoS. Acid
survival in the absence of theophylline was close to the
wild-type levels and decreased with increasing concentra-
tions of theophylline (Figure 5B). Acid survival reached
the minimum that was comparable to that of an rpoS
null mutant when theophylline was increased to 1600mM.
When increasing concentrations of IPTG were added to the
medium containing 1600mM theophylline, the acid survival
increased and was restored to the wild-type levels in the
presence of 40mM IPTG, consistent with the response
curve of the ON1-lacI strain. These rpoS data not only
confirmed the portability, tunability and two-way control
features of the ON-lacI–LacIbs device, but also suggested
the potential utility of this device in flexibly manipulating
virulence and immunogenicity of live vaccines and bacteria
for other medical purposes.
Figure 4. Magnified, tunable, two-way gene control mediated by the hybrid device ON-lacI–LacIbs. (A) Using the LacI repressor as a modulator,
the ON-lacI riboswitch indirectly controlled lacZ expression and its regulatory effects on lacZ were magnified compared to its effects on lacI. (B)
Tunable and two-way control of target gene mediated by the combinatorial use of the ON-lacI riboswitch and LacI-binding sites. Using LacI as a
modulator, the ON-lacI riboswitches finely tuned lacZ expression in response to theophylline (0–1600 mM) and reversed lacZ expression by adding
increasing concentrations of IPTG (0.16–40 mM) without removal of medium. Error bars represent standard deviation (*P< 0.05). (C) Kinetics of the
LacZ activity in the strain carrying ON-lacI–lacZ. 1600mM theophylline was added to exponentially growing culture at 0min, and 40 mM IPTG was
added to the culture at 120min. Samples were collected for measurement of LacZ activity at the indicated time points. All data were normalized to
the LacZ activity of the strain grown in LB medium plus 1600 mM caffeine.
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ON-lacI–LabIs coupled with a small non-coding RNA
CsrB for trans-acting regulation of autoaggregation
and biofilm formation
Next, we asked if we could accomplish trans-acting regu-
lation of target expression using the ON-lacI–LacIbs
device so that there is no need for chromosome engineer-
ing. We illustrated this using a naturally existing small
non-coding RNA CsrB which is well known as an antag-
onist of the CsrA protein (36). It has previously been
demonstrated that CsrB promotes cellular autoaggrega-
tion (4) and biofilm formation by indirectly activating the
expression of the pgaABCD operon via CsrA (37).
Considering these obvious phenotypes of CsrB-over-
producing cells, we decided to couple CsrB with the ON-
lacI–LacIbs device to control the pga operon (Figure 6A).
We cloned csrB in a multi-copy vector downstream of the
lac promoter to place the CsrB expression under the
control of the ON1-lacI switch. Since one LacIb is after
the transcriptional start site, the resulting CsrB slightly
differs from the native one by the extra 21-nt sequence
(i.e. LacIb). We induced the CsrB expression by IPTG
and observed that autoaggregation (which serves as an
indicator of CsrB expression) occurred (data not shown),
indicating that this CsrB is functional. We introduced this
CsrB-carrying vector into the ON1-lacI strain and exa-
mined autoaggregation and biofilm formation. In the
presence of caffeine and the absence of theophylline,
LacI levels were low and CsrB expression should be on
(Figure 6A). As predicted, the cells autoaggregated and
formed high levels of biofilms, showing that the pga ex-
pression was induced due to the overproduction of CsrB
(Figure 6B and C). In the presence of theophylline, lacI
expression is turned on and CsrB production should be
repressed by LacI. The repression of CsrB is expected
to result in upregulation of CsrA, which inhibits auto-
aggregation and biofilm formation (Figure 6A). In agree-
ment with this, the cells were negative with
autoaggregation and formed low levels of biofilms
(Figure 6B and C). When IPTG was added together
with theophylline, the activity of LacI was inhibited, and
CsrB should be at high levels (Figure 6A). In support of
this, autoaggregation and biofilm formation were restored
in the presence of IPTG and theophylline (Figure 6B and
C). The changes in CsrB expression in response to theo-
phylline and IPTG were also confirmed by semi-
quantitative RT–PCR (Figure 6D). These results demon-
strate that the hybrid device can be used in combination
with a small non-coding RNA to exert trans-acting
control of target expression, alleviating the need for modi-
fication of the chromosome and expanding the applica-
tions of this riboswitch system.
Use of ON-lacI–LacIbs to uncover a role of RpoS in
acetate assimilation
Next, we applied ON-lacI–LacIbs to identify new gene
functions that may otherwise be neglected using tradition-
al methods. It is well established that bacterial cells switch
from rapid growth that produces and excretes acetate (dis-
similation) in the presence of abundant nutrients to slower
growth supported by the import and utilization of the
excreted acetate (assimilation) when glucose is exhausted
[for a review, see reference (38)]. This physiological event
Figure 5. Gene control mediated by the ON-lacI–LacIbs hybrid device. (A) The ON-lacI–LacIbs hybrid device. The boxed is a portable riboswitch
cassette ON-lacI–LacIbs (LacI-binding sites) integrated immediately upstream of ribosome binding site of the rpoS gene that is a master regulator of
stress resistance (SR). (B) Tunable and two-way control of rpoS via the ON-lacI–LacIbs device, as revealed by acid survival. The strain ON-lacI–rpoS
that carried the ON-lacI–LacIbs device upstream of the ribosome binding site became increasingly sensitive to acid with theophylline (0–1600 mM).
When increasing concentrations of IPTG were added to cells grown in media with 1600 mM theophylline, acid survival was increased and restored to
wild-type levels in the presence of 40 mM IPTG. Error bars represent standard deviation.
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is defined as acetate switch, a survival response allowing
cells to compete successfully during carbon starvation. It
was previously reported that RpoS positively regulated
consumption of acetate by activating the expression of
acetyl-coenzyme A synthetase (Acs) (39,40). However,
we obtained opposite results with ON-lacI–rpoS. ON-
lacI–rpoS in the ON state in the absence of theophylline
and IPTG exhibited acetate assimilation similar to that of
the wild-type strain (Figure 7A). When grown in the
presence of theophylline (2mM) and absence of IPTG,
the rpoS expression was shut off (detailed above) and ac-
cordingly, the acetate assimilation was accelerated. When
IPTG (1mM) was added to the medium to free up the
rpoS expression, the acetate assimilation was restored to
the wild-type levels (Figure 7A). Neither theophylline nor
IPTG had effect on acetate assimilation of the wild-type
strain (data not shown), excluding the possible non-
specific effects of the two chemicals. The enhanced
acetate assimilation was also observed with the newly con-
structed rpoS null mutant (Figure 7B). All the cell suspen-
sions were adjusted to an OD of 0.08 prior to the acetate
assays, and the cells with varying RpoS activities showed
comparable cell growth rate (data not shown), ruling out
the possible effects of growth rate on acetate assimilation.
Taken together, RpoS represses acetate assimilation.
Next, we explored the underlying mechanism by which
RpoS regulates the ability to scavenge for extracellular
acetate. Acetate assimilation depends on the Acs and
the phosphotransacetylase (Pta)–acetate kinase (AckA)
pathway (38,41) (Figure 7C). We therefore proposed that
RpoS inhibited the Acs and/or the Pta–AckA pathway
and that deleting rpoS should increase their expression
levels. To test this hypothesis, we incubated the cells for
6 h when acetate switch had been flipped and then
examined the possible effects of RpoS on the levels of
Acs and AckA–Pta. Our b-galactosidase data showed
that the removal of rpoS slightly reduced the expression
of an acs-lacZ translational fusion on the chromosome,
excluding the first possibility. However, deleting rpoS
resulted in a 5-fold increase in the expression levels of
an ackA-lacZ translational fusion (Figure 7D). Pta and
ackA are in the same operon. The ackA-lacZ data
Figure 6. Trans-acting gene control through combinatorial use of the ON-lacI–LacIbs hybrid device and a small non-coding RNA CsrB. (A) Trans-
acting system and predicted autoaggregation (AG) and biofilm phenotypic changes of the ON-lacI strain carrying pLacIb-CsrB in response to
theophylline and IPTG. A csrB-carrying plasmid (pLacIb-CsrB) was transformed into the ON-lacI strain. The csrB gene was preceded by two
LacI-binding sites and thus under the control of the ON1-lacI riboswitch. (B) Scanned images of cell suspensions (stained with crystal violet) of the
ON1-lacI strain harboring pLacIb-CsrB in microtiter plates and fluorescence microscopic images of the corresponding cell suspensions (stained with
DAPI) in the absence of theophylline, in the presence of 2mM theophylline or in the presence of both 2mM theophylline and 1mM IPTG.
(C) Biofilm formation of the ON1-lacI strain harboring pLacIb-CsrB in the absence of theophylline, in the presence of 2mM theophylline or in
the presence of both 2mM theophylline and 1mM IPTG. (D) Detection of intracellular CsrB small non-coding RNA levels by semi-quantitative
reverse transcription-PCR. Total RNA was isolated from overnight cultures of the ON1-lacI strain carrying pLacIb-CsrB grown in the absence of
2mM theophylline, in the presence of 2mM theophylline or in the presence of both 2mM theophylline and 1mM IPTG. cDNA was amplified for 18,
20, 22 and 24 cycles using gene-specific primers. 16S rRNA was used as an internal control. PCR products formed after 18 cycles are included in the
agarose gel image shown in the figure, along with a DNA ladder (100-, 200-, 300-, and 400-bp bands indicated). Densitometry indicated that for both
the CsrB and 16S rRNA products, cycle 18 was within the linear range for the PCR amplification (data not shown). Expected product size for CsrB
and 16S rRNA is 347 and 200 bp, respectively. Error bars represent standard deviation (*P< 0.05).
PAGE 9 OF 13 Nucleic Acids Research, 2011, Vol. 39, No. 19 e131
revealed that the Pta–AckA pathway was enhanced in the
rpoS null mutant and the theophylline-grown ON-lacI–
rpoS cells, relative to that of the wild-type. It is followed
that the increased acetate assimilation as a result of the
rpoS repression (ON-lacI–rpoS in the presence of theo-
phylline) or deletion is at least partially due to the
elevated activity of the Pta–AckA pathway.
It is notable that our results on the role of RpoS in
acetate assimilation are opposite to those of previous
studies using rpoS mutants (39,40). rpoS mutants fre-
quently generate secondary mutations within the hns
gene (encoding H-NS, an abundant nucleoid-associated
protein) to compensate for the loss of RpoS function
(42). It is, therefore, likely that rpoS mutants used in
those studies might have accumulated analogous compen-
satory mutations and consequently exhibited the opposite
phenotype. If this is true, then cells deleted for hns,
compared to the wild type, should have a reduced ability
to scavenge for extracellular acetate. As predicted, re-
moving hns inhibited acetate assimilation as revealed by
sustained high levels of extracellular acetate (Figure 7B),
supporting the notion that the previous observations with
the rpoS mutants may result from compensatory muta-
tions in hns.
DISCUSSION
Here, we have used a library screening strategy for
creating riboswitches residing upstream of the lacI RBS.
Based on this strategy, we have further engineered a
portable riboswitch-LacP hybrid device that efficiently
regulates specific target genes without the need for rational
design. Using the LacI protein as a signal converter, the
hybrid device has accomplished portable and sequential
two-way control of target expression in response to theo-
phylline and IPTG. This two-way portable device can be
used to uncover protein functions that would otherwise be
neglected by using traditional genetic mutagenesis.
Two regulatory mechanisms have mainly been utilized
for constructing synthetic riboswitches: translational re-
pression (4,5,43) and mRNA destabilization based on
hammerhead-mediated RNA self-cleavage (8,44). Here,
we adopt the first strategy to create riboswitches for
lacI. Riboswitches, like other RNA molecules, are sensi-
tive to their sequence context and a subtle change in a
single nucleotide often makes a big difference to their sec-
ondary structures and functionality. We take advantage of
this feature and build up riboswitch libraries by grafting
a theophylline-responsive aptamer followed by a 5-nt
random sequence to target genes. The aptamer is used as
the sensor domain that selectively binds theophylline,
causes conformational changes and mediates downstream
gene expression. This sensor is integrated upstream of
RBS of target genes on the chromosome by recombineer-
ing. The five random bases in between the sensor and the
RBS allow for generation of a library which in principle
harbors 45 riboswitch candidates. Subsequent screening
on X-gal plates can efficiently identify functionally active
Figure 7. A role of RpoS in acetate assimilation. (A) Extracellular acetate concentration plotted as a function of time for the wild-type and the strain
ON-lacI–rpoS. (B) Extracellular acetate concentration plotted as a function of time for the wild-type strain and those deficient for rpoS or hns.
(C) Pathways of acetate assimilation in E. coli. Glc-6-P, glucose 6-phosphate; Pyr, pyruvate; Ac-CoA, acetyl coenzyme A; Acetyl-P, acetyl phosphate.
(D) LacZ activities of the strains carrying the acs–lacZ or ackA–lacZ translational fusion on the chromosome, with or without rpoS. Error bars
represent standard deviation (*P< 0.05).
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riboswitches. Unlike previously reported riboswitch libra-
ries that are all carried on plasmids (14–16), our libraries
are established on the chromosome with the aid of recom-
bineering. Therefore, our riboswitches are more genetical-
ly stable than the previous plasmid-harbored ones. We
built up a riboswitch random library for the lacI gene
that was fused in frame with lacZ whose expression
could be easily examined on X-gal plates. By checking
the color of colonies grown on X-gal plates with or
without theophylline, both ON and OFF riboswitches of
lacI were created. Structure predictions revealed that the
above riboswitches regulate the lacI expression by
adopting or disrupting a long stem structure immediately
upstream of the RBS in response to theophylline. The long
stem forms in the OFF state and fails to exist in the ON
state. Thus, the long stem besides the RBS is responsible
for the gene silencing mediated by the riboswitches, con-
sistent with previous reports (5).
Building on the synthetic riboswitches created in the
first part of the work, we constructed a portable and
two-way regulation device that act as a versatile key to
any target without rational design or library screening. We
achieved this by adopting the LacI repressor, which
inhibits transcription by binding to LacIbs, as a modula-
tor that links the ligand-responsive riboswitch to ultimate
targets. As described above, effective ON riboswitches had
been created for lacI. Upstream of the lacI gene in the
strain ON-lacI is a riboswitch cassette that carries all ne-
cessary regulation elements including the CmR gene (cat),
a constitutive promoter, the theophylline-responsive ON
riboswitch of lacI, the lacI gene and two LacIbs. Without
any sequence adjustment, we simply inserted this 2500-bp
cassette immediately upstream of the RBS of the rpoS
gene and showed that the ON-lacI riboswitch fine-tuned
rpoS expression (as revealed by acid survival). When
applied to the csrB gene, this device controlled the expres-
sion of the small non-coding RNA CsrB and consequently
modulated biofilm formation and cellular autoaggrega-
tion. The success of this device in regulating the expression
of lacZ, rpoS and csrB demonstrates its portability.
The combinatorial use of the ON riboswitch of lacI and
LacIbs has other advantages in addition to portability.
LacI can magnify the regulatory effects of the ON-lacI–
LacIbs device and maximize its dynamic range that is
defined as the ratio of the highest and lowest target
levels. Previous regulation systems mediate control of
gene expression in a one-way manner: target expression
is turned on in response to a specific inducer and turned
off when the inducer is removed by replacement of
medium. However, this maneuver is infeasible in animal
experiments and may cause problems in some demanding
bacterial experiments where cultures have to be kept intact.
The ON-lacI–LacIbs system overcomes this problem as its
target gene is in the ON state in the absence of theophyl-
line, switched off in response to the ligand, and switched
back to the ON state when IPTG is added without
removal of theophylline.
Finally, strains armed with this device are more genet-
ically stable and therefore provide more reliable informa-
tion compared to those constructed using traditional
approaches. It has been demonstrated that deleterious
mutations and those that cause reduced fitness can bring
about secondary mutations that compensate for undesired
changes (45–50). The compensatory mutations can give
misleading results in gene function studies and destabilize
geno- and phenotypes of genetically engineered bacteria
for medical and industrial purposes. One solution to min-
imize the compensatory mutations is to engineer a strain
in which the gene to be controlled is normally expressed
and not shut off unless an inducer is applied. Moreover, it
would be ideal if the wild-type levels of gene expression
could be restored in response to a second effector
molecule, to ensure that the observed mutation phenotype
is not caused by pleiotropic effects of the inducer. The
ON-lacI–LacIbs riboswitch device meets all these require-
ments. For example, the strain ON-lacI–rpoS exhibits
normal rpoS expression in the absence of theophylline
and IPTG and therefore has no fitness burden.
Therefore, compared to an rpoS null mutant, ON-lacI–
rpoS is less likely to accumulate compensatory mutations
and thus more reliable. Only in the presence of theophyl-
line, can ON-lacI–rpoS behavior as an rpoS mutant,
allowing for rpoS function investigation. Phenotypes in
the two ON states (in the absence of any inducer and in
the presence of both theophylline and IPTG) should be
identical, excluding the non-specific effects of theophyl-
line. Here, the use of the ON-lacI–LacIbs device helped
uncover a novel function of RpoS, which may otherwise
be neglected or misunderstood by using traditional
approaches. That is, RpoS inhibits acetate assimilation.
Acetate assimilation is a critical process allowing the cell
to efficiently utilize nutrient resources when favorable car-
bon sources are exhausted, and turning the waste product
acetate into a carbon and energy source. Acetate assimi-
lation is also responsible for managing levels of acetyl-coA
and acetyl phosphate, both of which are important central
metabolites [for a review, see reference (38)]. Interestingly,
previous studies reported the opposite results that RpoS
appeared to positively regulate acetate assimilation (39,40).
One explanation of the discrepancy is the above-
mentioned occurrence of compensatory mutations.
Indeed, it has been demonstrated that secondary muta-
tions within the hns gene frequently occur in strains
carrying rpoS mutations to compensate for the loss of
RpoS function (42). The action of H-NS is generally
opposite to that of RpoS (51), and H-NS downregulates
both rpoS mRNA translation and RpoS stability (52).
This, together with our observation that deleting hns
represses acetate assimilation makes it reasonable to
speculate that compensatory mutations within hns may
have occurred in the rpoS mutant strains used in the
previous studies so that they observed opposite pheno-
types with their rpoS mutants.
In summary, we have developed a portable device that
performs sequential OFF-and-ON gene regulation in
response to theophylline and IPTG, respectively. This
study also indicates that the number of gene control elem-
ents available to us can be greatly increased by combining
ligand-dependent riboswitches and inducer-responsive
promoters. Suppose the number of riboswitch ligands is
n and the number of inducers of inducible promoters is m,
then nm combinatorial control elements can be created,
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greatly enriching the repertory of gene regulatory elements.
Although this work focuses on developing a riboswitch-
LacP hybrid device in E. coli, similar strategy (i.e. a
ligand-responsive riboswitch integrated with an inducible
promoter system) may be extended to eukaryotic cells to
achieve portable, two-way expression regulation.
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